Clinical Trial Update: PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas [NA]

View source ↗

Summary

A clinical trial update for PRO-GLIO compares proton versus photon therapy in IDH-mutant diffuse gliomas and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Oligodendroglioma
• Diffuse Astrocytoma Idh-mutant
• Oligodendroglioma

Snippet

Sponsor: Oslo University Hospital | Conditions: Oligodendroglioma, Oligodendroglioma, Anaplastic | NA | Status: RECRUITING